Scientific and Clinical Development

The Scientific and Clinical Development team at AsclepiX Therapeutics is responsible for driving the research and development of innovative peptide therapies aimed at treating retinal diseases and cancer. This team collaborates on preclinical and clinical trials, ensuring that drug candidates are rigorously tested for efficacy and safety while coordinating with regulatory bodies to navigate the approval process. Their multidisciplinary expertise facilitates the translation of scientific discovery into therapeutic solutions, supporting the company’s mission to improve patient outcomes.